Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Reuters
Reuters
Business

BioNTech, Fosun launch another COVID-19 vaccine trial

FILE PHOTO: A booth of Shanghai Fosun Pharmaceutical Group Co Ltd is seen at a medical instruments and equipment expo in Beijing, China August 17, 2018. Picture taken August 17, 2018. REUTERS/Stringer

Germany's BioNTech and China's Shanghai Fosun Pharmaceutical on Wednesday announced the start of another COVID-19 vaccine trial in China with a total of 144 participants.

"The study is designed to support the regulatory approval process for the Chinese market and intends to confirm that the safety and immunogenicity profile observed in participants from the German and U.S. trials is comparable to that of Chinese participants," BioNTech said in a statement.

FILE PHOTO: A woman holds a small bottle labeled with a "Vaccine COVID-19" sticker and a medical syringe in this illustration taken April 10, 2020. REUTERS/Dado Ruvic/Illustration/File Photo

(Reporting by Thomas Seythal; Editing by Michelle Martin)

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.